Shares of Theravance Biopharma TBPH plunged 26% after the company announced the failure of the late-stage CYPRESS study ...

Theravance Biopharma said it is chopping its workforce by 50% and launching a review of strategic alternatives designed to maximize shareholder value, after its sole rare disease pipeline candidate, ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced topline results from the Phase 3 CYPRESS study evaluating the efficacy and safety of ampreloxetine ...

Wow! One hundred percent across the board! That is what Rodgers Forge Elementary School Principal Missy Fanshaw saw when she pulled up the results of the Maryland State Assessment Test.

Phase 3 CYPRESS study did not meet the primary endpoint, the OHSA Composite Score, a patient reported outcome (PRO) Cash of $326.5 million at Q4 2025 (no debt); ...

TSX-V: MSRTORONTO, Feb. 27, 2026 /CNW/ - Minsud Resources Corp. (TSXV: MSR) ("Minsud" or the "Company"), is pleased to report its Mineral Resource ...

Learn about unique Medicare insurance benefits that can help retirees save on health care costs and make the most of their ...

Super Jury of Industry Leaders Assemble to Judge 2026 Shortlisted Entries NEW YORK, NY, UNITED STATES, February 26, ...

Founded by Female Scientists, Inertia Introduces Patented Plant-Derived Absorbent Core Technology NEW YORK, NY, UNITED ...

Specialty Sauce Disruptor Eyes Expansion into Asia Following Nationwide U.S. and International Growth. With their motto “If You Can’t Pronounce it… It Ain’t in There”, customers have been lining up to ...

Medivest, a national leader in MSA administration and MSP compliance solutions, today announced that it has been ...

February 26, 2026 - PRESSADVANTAGE - Big Easy Electrical has formalized a no-cost assessment program designed to ...